Going anti-Viral

Епізоди

• 
  Special Episode - Latest Update on Emerging Infections and Health Threats 14.09.2026 1год 2хв

  In episode 87 of Going anti-Viral, we represent a panel discussion from September 3, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine...
• 
  Beyond the Diagnosis: Women and HIV in Latin America - Dr Brenda Crabtree-Ramírez 08.09.2026 30хв

  In episode 86 of Going anti-Viral, Dr Brenda Crabtree-Ramírez joins host Dr Michael Saag to discuss women and HIV in Latin America. Dr Crabtree-Ramírez is a Professor of the HIV Program at the Universidad Nacional Autónoma de México. She has participated in Phase I to IV clinical trials evaluating therapies for HIV/AIDS and opportunistic infections and is the Principal Investigator in Mexico for the Caribbean, Central, and South America Network for HIV Epidemiology (CCASAnet). She has contrib...
• 
  How HIV Research Drives Breakthroughs for Other Diseases - Dr Andrea Gramatica 25.08.2026 24хв

  In episode 85 of Going anti-Viral, Dr Andrea Gramatica joins host Dr Michael Saag to discuss the work of amfAR and how HIV research drives breakthroughs for other diseases. Dr Gramatica is Vice President of Research at amfAR and an expert in immunology and HIV virology with a research focus on viral persistence and immune modulation. Dr Gramatica is responsible for shaping the strategic direction of amfAR’s research programs, including building upon existing research into HIV and other viral ...
• 
  How USAID Was Dismantled—and What the World Lost - Nicholas Enrich 14.08.2026 44хв

  In episode 84 of Going anti-Viral, Nicholas Enrich joins host Dr Michael Saag to discuss his book Into the Wood Chipper: A Whistleblower's Account of How the Trump Administration Shredded USAID. Mr Enrich is a former civil servant who worked at the United States Agency for International Development (USAID) under 4 administrations. He served as the Bureau of Global Health director of policy, programs, and planning until January 2025, when he was designated as the USAID acting assistant adminis...
• 
  New Guidelines for Statin Use in People with HIV – REPRIEVE Trial Updates - Dr Steven Grinspoon 28.07.2026 28хв

  In episode 83 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to provide an update on guidelines for statin use in people with HIV based on results from the REPRIEVE trial. Dr Grinspoon is a Professor of Medicine at Harvard Medical School and a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesit...
• 
  Tracking Ebola — Outbreak Status and the International Response - Dr Tyler Evans 14.07.2026 31хв

  In episode 82 of Going anti-Viral, Dr Tyler Evans joins host Dr Michael Saag to discuss the Ebola outbreak in the Democratic Republic of the Congo and Uganda and the global response. Dr Evans is an infectious diseases and addiction medicine physician and CEO of Wellness Equity Alliance, a national organization advancing health equity in the US and globally. He is also an associate professor of population and public health sciences at the University of Southern California Keck School of Medici...
• 
  Progress in HIV Cure Research: Can a Single Shot Deliver a Functional Cure? - Dr Steven Deeks 30.06.2026 31хв

  In episode 81 of Going anti-Viral, Dr Steven Deeks joins host Dr Michael Saag to discuss recent research demonstrating the promise of a single shot in a functional cure of HIV. Dr Deeks is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment and is...
• 
  TMVII: Understanding the Emergence of Trichophyton mentagrophytes Genotype VII – Dr Jason Zucker 16.06.2026 19хв

  In episode 80 of Going anti-Viral, Dr Jason Zucker joins host Dr Michael Saag to provide an update on the Trichophyton mentagrophytes genotype VII (TMVII) infection. Dr Zucker is an Assistant Professor of Medicine at Columbia University and Assistant Medical Director of the New York City STD Prevention Training Center. Dr Zucker is an experienced HIV, HIV prevention, and sexual health care provider providing status-neutral care to patients of all ages in New York. His research focuses on the ...
• 
  Special Episode - Latest Update on Emerging Infections and Health Threats 12.06.2026 1год 2хв

  In episode 79 of Going anti-Viral, we represent a panel discussion from June 9, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, thi...
• 
  From Data to Guidance: The Process Behind Clinical Guidelines – Dr Rajesh Gandhi 02.06.2026 30хв

  In episode 78 of Going anti-Viral, Dr Rajesh T. Gandhi joins host Dr Michael Saag to discuss the process of guidelines development. Dr Gandhi is a Professor of Medicine at Harvard Medical School and Principal Investigator and Co-Director of the Harvard University Center for AIDS Research (CFAR). Dr Gandhi is the Vice-Chair of the ACTG, Vice-Chair of the Infectious Diseases Society of America COVID-19 Treatment Guidelines Panel, Chair of the International Antiviral Society-USA Panel on Antiret...
• 
  Management of Hepatitis B Virus Infection and Vaccination – Dr Debika Bhattacharya 19.05.2026 32хв

  In episode 77 of Going anti-Viral, Dr Debika Bhattacharya joins host Dr Michael Saag to discuss the management of hepatitis B virus (HBV) infection and vaccination. Dr Bhattacharya is a Clinical Professor at the University of California Los Angeles (UCLA) David Geffen School of Medicine and specializes in the management of HIV and HIV/viral hepatitis coinfection and sees patients with viral hepatitis and HIV/viral hepatitis coinfection at UCLA and its affiliated clinics. Her research involves...
• 
  The Impact of Long-acting Injectable HIV Treatments on Public Health – Dr Kelly Gebo 05.05.2026 26хв

  In episode 76 of Going anti-Viral, Dr Kelly Gebo joins host Dr Michael Saag to discuss the impact of long-acting injectable HIV treatments on public health. Dr Gebo is Dean of the Milken Institute School of Public Health at the George Washington University. An infectious disease physician-scientist, educator, and accomplished academic leader, Dr Gebo’s work focuses on health equity, access to care, and outcomes for people affected by infectious diseases such as HIV, COVID-19, and Mpox. Dr Geb...
• 
  Cognitive Aging in HIV: Clinical Assessment and Management – Dr Shibani Mukerji 21.04.2026 37хв

  In episode 75 of Going anti-Viral, Dr Shibani Mukerji joins host Dr Michael Saag to discuss a presentation she gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Cognitive Aging in HIV: Clinical Assessment and Management. Dr Mukerji is an Associate Professor of Neurology at Harvard Medical School and is a practicing neurologist in the Department of Neurology and Division of Infectious Diseases at Massachusetts General Hospital. Her research focuses on HIV...
• 
  Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater 07.04.2026 27хв

  In episode 74 of Going anti-Viral, Dr John Frater joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026. Dr Frater is a Professor of Infectious Diseases at the University of Oxford where he leads the HIV Reservoir and Cure Group. The aim of his research is to explore strategies for targeting the reservoir of latent...
• 
  Special Episode - Latest Update on Emerging Infections and Health Threats 01.04.2026 1год 4хв

  In episode 73 of Going anti-Viral, we represent a panel discussion from March 26, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, t...
• 
  Neurodegeneration and Dementia Risk in Older Adults with HIV: Biomarkers and Epidemiology – Dr Alan Winston 24.03.2026 28хв

  In episode 72 of Going anti-Viral, Dr Alan Winston joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Neurodegeneration and Dementia Risk in Older Adults With HIV: Biomarkers and Epidemiology. Dr Winston is a Professor of HIV and Genitourinary Medicine at Imperial College London and Consultant Physician at St. Mary's Hospital, London. His research focuses on noninfectious comorbidities associated wit...
• 
  CROI 2026 Review: What’s New, What’s Next in HIV Research – Dr Peter Hunt 10.03.2026 31хв

  In episode 71 of Going anti-Viral, Dr Peter Hunt joins host Dr Michael Saag to provide a review of the science presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI). Dr Hunt is a Professor of Medicine at the University of California San Francisco and is the Associate Chief for Research in the Zuckerberg San Francisco General Hospital Department of Medicine, and Co-Director of the UCSF-Bay Area Center for AIDS Research for Basic and Translational Science. He was ...
• 
  From Wall Street to ACT UP: A Life Rewritten by HIV - Peter Staley 27.02.2026 41хв

  In episode 70 of Going anti-Viral, Peter Staley joins host Dr Michael Saag after giving the Martin Delaney presentation at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled ''Annus Horribilis" and The War on Science: Thoughts on Resisting and Rebuilding. Mr Staley shares his inspiring story as a pioneering HIV and LGBTQ+ rights activist, recounting his journey from the early days of the AIDS crisis to groundbreaking activism leading to a seat at the table with c...
• 
  Successes in HIV-1 Vaccine Design: Accelerating Completion of One of Sciences’ Most Difficult Vaccines – Dr Kevin Saunders 25.02.2026 27хв

  In episode 69 of Going anti-Viral, Dr Kevin Saunders joins host Dr Michael Saag to discuss a plenary presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Successes in HIV-1 Vaccine Design: Accelerating Completion of One of Sciences’ Most Difficult Vaccines. Dr Saunders is the associate director for the Duke Human Vaccine Institute and the Norman L. Letvin Professor in Immunology and Infectious Diseases Research. Dr Saunders leads a translati...
• 
  Strategic and Resilient Responses to the Funding Crisis Across Africa – Dr Ruanne Barnabas 19.02.2026 24хв

  In episode 68 of Going anti-Viral, Dr Ruanne Barnabas joins host Dr Michael Saag to discuss topic of a symposium session at the upcoming the Conference on Retroviruses and Opportunistic Infections (CROI) entitled Strategic and Resilient Responses to the Funding Crisis Across Africa. Dr Barnabas is the Chief of the Division of Infectious Diseases at Massachusetts General Hospital. Her work is focused on identifying effective and scalable HIV, HPV, and infectious diseases treatment and preventi...